Related Experiment Video
Updated: Mar 29, 2026

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
1.3K
Pseudotumors of the placenta
1Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 171 Ashley Ave, MSC 908, Charleston, South Carolina 29425-9080.
Seminars in Diagnostic Pathology
|November 26, 2015
Summary
Surgical pathologists frequently examine placental specimens. This review highlights rare placental tumors and common non-neoplastic lesions that can mimic malignancy, aiding accurate diagnosis and preventing patient distress.
Area of Science:
- Reproductive Medicine
- Pathology
- Obstetrics
Background:
- The placenta is a common specimen in surgical pathology.
- Primary placental tumors are exceptionally rare.
- Non-neoplastic placental lesions can mimic malignancy.
Purpose of the Study:
- To review rare primary placental tumors.
- To discuss non-neoplastic placental lesions that mimic malignancy.
- To emphasize the importance of recognizing diagnostic pitfalls in placental pathology.
Main Methods:
- Review of literature on placental pathology.
- Analysis of gross and microscopic features of placental lesions.
- Emphasis on differential diagnosis between neoplastic and non-neoplastic entities.
Main Results:
- While primary placental tumors are rare, numerous non-neoplastic mass-forming lesions exist.
- Certain microscopic findings can be mistaken for malignancy.
- Awareness of these mimics is crucial for accurate diagnosis.
Conclusions:
- Accurate diagnosis of placental pathology requires knowledge of both rare tumors and common mimics.
- Distinguishing benign mimics from true malignancy prevents misdiagnosis and unnecessary patient anxiety.
- Understanding potential pitfalls in placental examination is essential for surgical pathologists.
More Related Videos
Related Concept Videos
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Fetal Circulation
4.5K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.5K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K

